Clinical, MRI, and CSF markers of disability progression in multiple sclerosis. (Q30712257)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24324285%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

review article

0 references

title

Clinical, MRI, and CSF markers of disability progression in multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24324285%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

0 references

2 references

25 April 2019

30 June 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24324285%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Massimiliano Calabrese

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24324285%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Maria Donata Benedetti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24324285%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Salvatore Monaco

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24324285%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Massimiliano Calabrese

2

1 reference

19 August 2017

Maria Donata Benedetti

3

1 reference

19 August 2017

Salvatore Monaco

4

1 reference

19 August 2017

10 November 2013

3 references

25 April 2019

30 June 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24324285%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

3 references

25 April 2019

30 June 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24324285%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24324285%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24324285%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

687-699

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24324285%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 3.0 Unported

2 March 2020

copyright license

start time

1 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Measurement and clinical effect of grey matter pathology in multiple sclerosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Total-tau in cerebrospinal fluid of patients with multiple sclerosis decreases in secondary progressive stage of disease and reflects degree of brain atrophy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Inflammatory cortical demyelination in early multiple sclerosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Tau protein: a possible prognostic factor in optic neuritis and multiple sclerosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

The neuropathological basis of clinical progression in multiple sclerosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Thalamic damage and long-term progression of disability in multiple sclerosis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

New perspectives in the natural history of multiple sclerosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Impact of multiple sclerosis relapses on progression diminishes with time

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Will Rogers phenomenon in multiple sclerosis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

A multifactorial prognostic index in multiple sclerosis. Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

The complex genetics of multiple sclerosis: pitfalls and prospects

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Primary-progressive multiple sclerosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Widespread demyelination in the cerebellar cortex in multiple sclerosis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Environmental risk factors for multiple sclerosis. Part I: The role of infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

MRI to monitor treatment efficacy in multiple sclerosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

The blood-brain barrier in cortical multiple sclerosis lesions

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Multimodal evoked potentials to assess the evolution of multiple sclerosis: a longitudinal study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Natural history of multiple sclerosis: a unifying concept

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Biological markers in CSF and blood for axonal degeneration in multiple sclerosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Development of biomarkers in multiple sclerosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Axonal transection in the lesions of multiple sclerosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Axonal damage in acute multiple sclerosis lesions

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Defining the clinical course of multiple sclerosis: Results of an international survey

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

The longstanding MS lesion. A quantitative MRI and electron microscopic study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions

20 June 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Is optic neuritis more benign than other first attacks in multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

The onset location of multiple sclerosis predicts the location of subsequent relapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Disability progression in multiple sclerosis is slower than previously reported.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Natural history of multiple sclerosis in a population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Clinical and conventional MRI predictors of disability and brain atrophy accumulation in RRMS. A large scale, short-term follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Predicting short-term disability in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Brain atrophy and lesion load predict long term disability in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

The changing clinical course of multiple sclerosis: a matter of gray matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Focal thinning of the cerebral cortex in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Localization of grey matter atrophy in early RRMS : A longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Cortical atrophy is relevant in multiple sclerosis at clinical onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Regional hippocampal atrophy in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Cortical lesion load associates with progression of disability in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Age at disability milestones in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Natural history of multiple sclerosis with childhood onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Truly benign multiple sclerosis is rare: let's stop fooling ourselves--commentary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

'Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Prediction of long-term disability in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Magnetic resonance evidence of cerebellar cortical pathology in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Spinal-cord MRI in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Tau protein in cerebrospinal fluid: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

14-3-3 Protein in the cerebrospinal fluid of patients with acute transverse myelitis and multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Regional brain atrophy development is related to specific aspects of clinical dysfunction in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Relating neocortical pathology to disability progression in multiple sclerosis using MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

CSF 14-3-3 protein assay and MRI as prognostic markers in patients with a clinically isolated syndrome suggestive of MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Familial effects on the clinical course of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Clinical impact of early brain atrophy in clinically isolated syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Predicting progression in primary progressive multiple sclerosis: A 10-year multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Visual and motor evoked potentials in the course of multiple sclerosis

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842089

Natural history of secondary-progressive multiple sclerosis

25 November 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Longitudinal follow-up of "benign" multiple sclerosis at 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F484959

Cerebrospinal fluid total tau protein levels in patients with multiple sclerosis

21 January 2018

1 reference

12 December 2020

T1 lesion load and cerebral atrophy as a marker for clinical progression in patients with multiple sclerosis. A prospective 18 months follow-up study

1 reference

12 December 2020

Cerebrospinal fluid brain specific proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis

1 reference

12 December 2020

Factors associated with the risk of secondary progression in multiple sclerosis

1 reference

12 December 2020

Evoked potential abnormality scores are a useful measure of disease burden in relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Influence of oligoclonal IgM specificity in multiple sclerosis disease course

1 reference

12 December 2020

Neurofilament light as a prognostic marker in multiple sclerosis

1 reference

12 December 2020

Relapses and progression of disability in multiple sclerosis

1 reference

12 December 2020

Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis

1 reference

12 December 2020

Magnetic resonance imaging predictors of disability in primary progressive multiple sclerosis: a 5-year study

1 reference

12 December 2020

Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS

1 reference

12 December 2020

1 reference

12 December 2020

Spinal cord atrophy and disability in multiple sclerosis

1 reference

12 December 2020

Increased cerebrospinal fluid tau protein in multiple sclerosis

1 reference

12 December 2020

Gray matter atrophy is related to long-term disability in multiple sclerosis

1 reference

12 December 2020

Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters

1 reference

12 December 2020

Neurofilament and glial fibrillary acidic protein in multiple sclerosis

1 reference

12 December 2020

The 14-3-3 protein in multiple sclerosis: a marker of disease severity

1 reference

12 December 2020

Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography

1 reference

12 December 2020

Biological markers for axonal degeneration in CSF and blood of patients with the first event indicative for multiple sclerosis

1 reference

12 December 2020

Tau protein concentrations in cerebrospinal fluid of patients with multiple sclerosis

1 reference

12 December 2020

Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study

1 reference

12 December 2020

Cerebrospinal fluid biomarkers in clinically isolated syndromes and multiple sclerosis

1 reference

12 December 2020

Predictive value of clinical characteristics for 'benign' multiple sclerosis

1 reference

12 December 2020

Tau protein seems not to be a useful routine clinical marker of axonal damage in multiple sclerosis

1 reference

12 December 2020

Identifiers

DOI

10.1155/2013/484959

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24324285%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24324285%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

PubMed publication ID

24324285

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24324285%20AND%20SRC:MED&resulttype=core&format=json